Tag: Medical Research
Navigating Pharma’s Patent Cliff: Impact on Obesity Fundraising and ALS Research
Navigating Pharma's Patent Cliff: Impact on Obesity Fundraising and ALS ResearchIn the fast-paced world of biotech, the looming patent cliff is causing a stir...
Lung Cancer Drug by Johnson & Johnson Boosts Survival Rate
Johnson & Johnson's Breakthrough Lung Cancer Drug Shows Promise in Boosting Survival RatesIn a groundbreaking development in the fight against non-small cell lung cancer,...
Revolutionary Biotech Battle: Impact on Transplants in Mantle Cell Lymphoma
Revolutionary Biotech Battle: Impact on Transplants in Mantle Cell LymphomaIn a groundbreaking showdown at the ASH 2024 conference, the biotech world witnessed an intense...
Ending 23andMe’s Drug Discovery Dream: What Went Wrong?
23andMe, the genetics company that many people have been excited about, recently made a big announcement. The company has decided to stop working on...
Assessing the Cost-Effectiveness of Alzheimer’s Drug Donanemab in the U.K.
The recent decision by the U.K.'s National Institute for Health and Care Excellence (NICE) regarding the cost-effectiveness of the Alzheimer's drug Donanemab, also known...
Overcoming Challenges of Traditional Trials in Ultra-Rare Diseases: The Case of Barth Syndrome
Ultragenyx's founder and CEO, Kakkis, is at the forefront of developing another treatment for an ultra-rare disease called Barth syndrome. This genetic disorder affects...
Pfizer CEO’s Vision for Leading Cancer and Obesity Treatments
Albert Bourla, the CEO of Pfizer, is looking to shift the focus of the company from its successful COVID-19 vaccine and antiviral Paxlovid to...
Accurate Alzheimer’s Diagnosis: Blood Test with 90% Success Rate
Scientists have recently made a significant advancement in the quest for a simple blood test to accurately diagnose Alzheimer's disease. The study, published in...
BREAKING NEWS
Medicare Coverage of Wegovy Should Include, But Not Negotiate Price
Title: Biden Administration's Decision on Wegovy Medicare Coverage Sparks ControversyPresident Biden's recent announcement regarding the Medicare coverage of Wegovy, a GLP-1 obesity medication, has...
